These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16096817)

  • 21. Cognitive-perceptual examination of remediation approaches to hypokinetic dysarthria.
    McAuliffe MJ; Kerr SE; Gibson EM; Anderson T; LaShell PJ
    J Speech Lang Hear Res; 2014 Aug; 57(4):1268-83. PubMed ID: 24687031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of voice onset time in dysarthric patients: methodological considerations.
    Ozsancak C; Auzou P; Jan M; Hannequin D
    Folia Phoniatr Logop; 2001; 53(1):48-57. PubMed ID: 11125260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dysarthria across Parkinson's disease progression. Natural history of its components: dysphonia, dysprosody and dysarthria].
    Pinto S; Ghio A; Teston B; Viallet F
    Rev Neurol (Paris); 2010 Oct; 166(10):800-10. PubMed ID: 20800250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The physical significance of acoustic parameters and its clinical significance of dysarthria in Parkinson's disease.
    Yang S; Wang F; Yang L; Xu F; Luo M; Chen X; Feng X; Zou X
    Sci Rep; 2020 Jul; 10(1):11776. PubMed ID: 32678256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceptual assessment of dysarthria: Comparison of a general and a detailed assessment protocol.
    Wannberg P; Schalling E; Hartelius L
    Logoped Phoniatr Vocol; 2016 Dec; 41(4):159-67. PubMed ID: 26443894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Markerless Analysis of Articulatory Movements in Patients With Parkinson's Disease.
    Bandini A; Orlandi S; Giovannelli F; Felici A; Cincotta M; Clemente D; Vanni P; Zaccara G; Manfredi C
    J Voice; 2016 Nov; 30(6):766.e1-766.e11. PubMed ID: 26620259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Speech and swallowing disturbances in corticobasal degeneration.
    Frattali CM; Sonies BC
    Adv Neurol; 2000; 82():153-60. PubMed ID: 10624479
    [No Abstract]   [Full Text] [Related]  

  • 28. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
    J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reception of Communicative Functions of Prosody in Hypokinetic Dysarthria due to Parkinson's Disease.
    Martens H; Van Nuffelen G; Wouters K; De Bodt M
    J Parkinsons Dis; 2016; 6(1):219-29. PubMed ID: 26889630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perceptual Characterization of Voice Quality in Nonadvanced Stages of Parkinson's Disease.
    Thijs Z; Watts CR
    J Voice; 2022 Mar; 36(2):293.e11-293.e18. PubMed ID: 32703725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pneumophonic coordination impairments in parkinsonian dysarthria: importance of aerodynamic parameters measurements.
    Moustapha SM; Alain G; Robert E; Bernard T; Mourtalla KM; Lamine G; François V
    West Afr J Med; 2012; 31(2):129-34. PubMed ID: 23208484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Relationship Between Speech Characteristics and Motor Subtypes of Parkinson's Disease.
    Brown KA; Spencer KA
    Am J Speech Lang Pathol; 2020 Nov; 29(4):2145-2154. PubMed ID: 32997516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of visual information on the intelligibility of dysarthric speech.
    Keintz CK; Bunton K; Hoit JD
    Am J Speech Lang Pathol; 2007 Aug; 16(3):222-34. PubMed ID: 17666548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Speech characteristics of patients with pallido-ponto-nigral degeneration and their application to presymptomatic detection in at-risk relatives.
    Liss JM; Krein-Jones K; Wszolek ZK; Caviness JN
    Am J Speech Lang Pathol; 2006 Aug; 15(3):226-35. PubMed ID: 16896172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparing an E-learning-based Speech Therapy (EST) efficacy study: Identifying suitable outcome measures to detect within-subject changes of speech intelligibility in dysarthric speakers.
    Beijer LJ; Rietveld AC; Ruiter MB; Geurts AC
    Clin Linguist Phon; 2014 Dec; 28(12):927-50. PubMed ID: 25025268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Speech technology-based assessment of phoneme intelligibility in dysarthria.
    Van Nuffelen G; Middag C; De Bodt M; Martens JP
    Int J Lang Commun Disord; 2009; 44(5):716-30. PubMed ID: 18821111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perceptual Classification of Motor Speech Disorders: The Role of Severity, Speech Task, and Listener's Expertise.
    Pernon M; Assal F; Kodrasi I; Laganaro M
    J Speech Lang Hear Res; 2022 Aug; 65(8):2727-2747. PubMed ID: 35878401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of dysarthria types based on perceptual analysis.
    Zyski BJ; Weisiger BE
    J Commun Disord; 1987 Oct; 20(5):367-78. PubMed ID: 3655012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left-hemispheric dominance for articulation: a prospective study on acute ischaemic dysarthria at different localizations.
    Urban PP; Rolke R; Wicht S; Keilmann A; Stoeter P; Hopf HC; Dieterich M
    Brain; 2006 Mar; 129(Pt 3):767-77. PubMed ID: 16418180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.